🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of niraparib in ...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2019-01-25
Trial ID
NCT03748641
This is a a Multicenter, Open-label, Single-arm, Phase Ib Dose Escalation a...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-02-03
Trial ID
NCT04178460
Treatments Being Tested
Colorectal Cancer ranks third among the most frequent malignancies represen...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-04
Trial ID
NCT05412706
Treatments Being Tested
This is an open-label, multicenter, extension study. Patients who are recei...
Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Start Date
2019-02-28
Trial ID
NCT03768063
The purpose of this research study is to see how useful it is to look at bi...
Status
Unknown
Location
Princess Margaret Cancer Centre
Start Date
2023-02-23
Trial ID
NCT05065021
Treatments Being Tested
Background: High-grade serous epithelial ovarian cancer is a disease with a...
Status
Recruiting
Location
CHU de Nîmes
Start Date
2020-10-01
Trial ID
NCT06827353
Treatments Being Tested
The human epidermal growth factor receptor 2 (HER2) regulates cell growth a...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-09-06
Trial ID
NCT03368729
Treatments Being Tested
This is an interventional trial. The goal of this clinical trial is dose fi...
Status
Recruiting
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2024-09-26
Trial ID
NCT06594679
Treatments Being Tested
This phase Ib trial studies the side effects and best dose of niraparib whe...
Status
Completed
Location
University of Alabama
Start Date
2017-09-22
Trial ID
NCT03076203
Treatments Being Tested